Cart
sales@molnova.com
Cyclosporine
CAS No. 79217-60-0
Cyclosporine ( —— )
Catalog No. M19109 CAS No. 79217-60-0
Cyclosporine is a calcineurin phosphatase pathway inhibitor, used as an immunosuppressant drug to prevent rejection in organ transplantation.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 42 | In Stock |
|
| 50MG | 80 | In Stock |
|
| 100MG | 115 | In Stock |
|
| 500MG | 293 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCyclosporine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclosporine is a calcineurin phosphatase pathway inhibitor, used as an immunosuppressant drug to prevent rejection in organ transplantation.
-
DescriptionCyclosporine is a calcineurin phosphatase pathway inhibitor, used as an immunosuppressant drug to prevent rejection in organ transplantation.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorcalcineurin phosphatase
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number79217-60-0
-
Formula Weight1202.61
-
Molecular FormulaC62H111N11O12
-
Purity98%
-
Solubility——
-
SMILESCCC1NC(=O)C([C@H](O)[C@H](C)C/C=C/C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hojo M,etal.Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature. 1999 Feb 11;397(6719):530-4.
molnova catalog
related products
-
TP-4748
TP-4748 is a biochemical.
-
DHBP
DHBP is an WalKR TCS activator. It works via targeting walk and selectively promoting the lysostaphin-induced lysis activity of the Newman wild-type strain.
-
MID-1
MID-1 is an inhibitor of MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) interaction.?It disrupts molecular association of MG53 with IRS-1 and abolishes MG53-induced IRS-1 ubiquitination and degradation in skeletal muscle, leading to elevated IRS-1 expression level and increased insulin signaling and glucose uptake.
